A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT04794010 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04794010
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2020-12-22
Primary completion: 2027-12-22
Enrollment: 825

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.